Published in J Health Organ Manag on January 01, 2012
Setting Healthcare Priorities at the Macro and Meso Levels: A Framework for Evaluation. Int J Health Policy Manag (2015) 0.86
Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science. BMC Med Res Methodol (2016) 0.78
Healthcare resource allocation decisions affecting uninsured services. J Health Organ Manag (2016) 0.75
Don't Discount Societal Value in Cost-Effectiveness Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness". Int J Health Policy Manag (2017) 0.75
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Setting priorities in global child health research investments: universal challenges and conceptual framework. Croat Med J (2008) 2.93
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health Aff (Millwood) (2006) 2.87
Alcohol use in motion pictures and its relation with early-onset teen drinking. J Stud Alcohol (2006) 2.73
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol (2003) 2.67
The Common Drug Review: a NICE start for Canada? Health Policy (2005) 2.58
Public participation in health care priority setting: A scoping review. Health Policy (2009) 2.52
Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics (2005) 2.16
Exposure to movie smoking among US adolescents aged 10 to 14 years: a population estimate. Pediatrics (2007) 1.95
Cost effectiveness analysis in health care: contraindications. BMJ (2002) 1.80
Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristics. Pediatr Blood Cancer (2010) 1.78
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis. Lung Cancer (2012) 1.62
Management of hypoplastic left heart syndrome in the 1990s. Am J Cardiol (2002) 1.61
Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol (2002) 1.58
Programme budgeting and marginal analysis: bridging the divide between doctors and managers. BMJ (2005) 1.52
Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy (2006) 1.52
Ownership of alcohol-branded merchandise and initiation of teen drinking. Am J Prev Med (2006) 1.50
Priority setting in Ontario's LHINs: ethics and economics in action. Healthc Q (2011) 1.45
Nutrition and exercise environment available to outpatients, visitors, and staff in Children's hospitals in Canada and the United States. Arch Pediatr Adolesc Med (2006) 1.34
Using economics to set pragmatic and ethical priorities. BMJ (2006) 1.33
Racial variation in treatment preferences and willingness to randomize in the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976) (2006) 1.32
Using PBMA in health care priority setting: description, challenges and experience. Appl Health Econ Health Policy (2003) 1.19
Priority setting in the provincial health services authority: survey of key decision makers. BMC Health Serv Res (2007) 1.15
International comparison of comparative effectiveness research in five jurisdictions: insights for the US. Pharmacoeconomics (2010) 1.15
Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in calgary, Canada. Clin Infect Dis (2002) 1.10
History and measurement of continuity of care in mental health services and evidence of its role in outcomes. Psychiatr Serv (2003) 1.09
Identifying research priorities for health care priority setting: a collaborative effort between managers and researchers. BMC Health Serv Res (2009) 1.07
Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci (2005) 1.06
A cluster randomized controlled trial comparing three methods of disseminating practice guidelines for children with croup [ISRCTN73394937]. Implement Sci (2006) 1.06
Access to cancer drugs in Canada: looking beyond coverage decisions. Healthc Policy (2011) 1.05
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009. PLoS One (2012) 1.02
Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: a systematic review. Int J Technol Assess Health Care (2013) 1.01
Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol (2006) 1.00
Overcoming barriers to priority setting using interdisciplinary methods. Health Policy (2009) 1.00
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Health Qual Life Outcomes (2011) 0.98
Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis. J Thorac Oncol (2011) 0.95
Movie character smoking and adolescent smoking: who matters more, good guys or bad guys? Pediatrics (2009) 0.94
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. Int J Cancer (2014) 0.94
Frequency and adequacy of depression treatment in a Canadian population sample. Can J Psychiatry (2007) 0.94
Assessing the capacity of the health services research community in Australia and New Zealand. Aust New Zealand Health Policy (2005) 0.94
Introducing priority setting and resource allocation in home and community care programs. J Health Serv Res Policy (2008) 0.93
Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument. Ophthalmic Epidemiol (2012) 0.92
Using participatory action research to build a priority setting process in a Canadian Regional Health Authority. Soc Sci Med (2006) 0.92
Communication of bed allocation decisions in a critical care unit and accountability for reasonableness. BMC Health Serv Res (2005) 0.91
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer. Oncologist (2012) 0.91
System tools for system change. BMJ Qual Saf (2011) 0.90
A community of practice for knowledge translation trainees: an innovative approach for learning and collaboration. J Contin Educ Health Prof (2013) 0.90
Evaluation of the impact of program budgeting and marginal analysis in Vancouver Island Health Authority. J Health Serv Res Policy (2009) 0.90
Pulmonary adenocarcinoma with metastasis to skeletal muscle in a cat. Can Vet J (2006) 0.89
Centralized drug review processes: are they fair? Soc Sci Med (2006) 0.87
Decision maker views on priority setting in the Vancouver Island Health Authority. Cost Eff Resour Alloc (2008) 0.87
Case study on priority setting in rural Southern Alberta: keeping the house from blowing in. Can J Rural Med (2004) 0.86
Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Appl Health Econ Health Policy (2006) 0.86
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes (2013) 0.86
Knowledge translation in the discourse of professional practice. Int J Evid Based Healthc (2011) 0.85
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers. BMC Cancer (2013) 0.84
Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature. Expert Rev Pharmacoecon Outcomes Res (2013) 0.84
Drug formulary decision-making in two regional health authorities in British Columbia, Canada. Health Policy (2008) 0.84
Health services research, policy and practice in Australia and New Zealand: a coming of age. J Health Serv Res Policy (2004) 0.83
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis. BMC Cancer (2014) 0.83
Breaking the addiction to technology adoption. Health Econ (2014) 0.82
Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework. Expert Rev Pharmacoecon Outcomes Res (2010) 0.82
Cost-effectiveness of therapies for melanoma. Expert Rev Pharmacoecon Outcomes Res (2015) 0.82
Strengths and limitations of competitive versus non-competitive models of integrated capitated fundholding. J Health Serv Res Policy (2002) 0.81
Quality and cost in healthcare: a relationship worth examining. Appl Health Econ Health Policy (2006) 0.80
Physician involvement in setting priorities for health regions. Healthc Manage Forum (2004) 0.80
Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national survey. BMC Health Serv Res (2013) 0.80
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis. BMC Health Serv Res (2013) 0.80
Guidelines for health technologies: specific guidance for oncology products in Canada. Value Health (2012) 0.80
Racial and economic disparity and the treatment of pediatric fractures. J Pediatr Orthop (2005) 0.79
We know accurately only when we know little. Pharmacoeconomics (2010) 0.79
Update in pain medicine. J Gen Intern Med (2008) 0.79
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada. Eur J Cancer (2012) 0.78
The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada. Cost Eff Resour Alloc (2013) 0.78
Community dental clinics: providers' perspectives. Community Dent Oral Epidemiol (2012) 0.78
Size matters: how age and reaching experiences shape infants' preferences for different sized objects. Infant Behav Dev (2013) 0.78
Sustaining organizational culture change in health systems. J Health Organ Manag (2016) 0.78
Moral distress among health system managers: exploratory research in two British Columbia health authorities. Health Care Anal (2011) 0.78
Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study). J Oncol Pharm Pract (2008) 0.77
Application of economic principles in healthcare priority setting. Expert Rev Pharmacoecon Outcomes Res (2006) 0.77
How to control the costs of health care services--an inventory of strategic options. Healthc Manage Forum (2009) 0.77
Moral Distress among Healthcare Managers: Conditions, Consequences and Potential Responses. Healthc Policy (2010) 0.76
The reallocation challenge: Containing Canadian medical care spending to invest in the social determinants of health. Can J Public Health (2016) 0.76
Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey. Patient (2015) 0.76
From the trenches: views from decision-makers on health services priority setting. Health Serv Manage Res (2005) 0.76
Developing a multi-criteria approach for drug reimbursement decision making: an initial step forward. J Popul Ther Clin Pharmacol (2015) 0.75
Qualitative methodologies in health-care priority setting research. Health Econ (2009) 0.75
Social welfare and the Affordable Care Act: is it ever optimal to set aside comparative cost? Soc Sci Med (2012) 0.75
An argument for explicit rationing of health resources within the public-private mix in Brazil. Cad Saude Publica (2012) 0.75